MD Anderson ranked top cancer hospital in annual survey

The University of Texas MD Anderson Cancer Center again has ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. Since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals, and it has ranked first 13 times in the last 16 years.

“To consistently be recognized for the quality and compassionate cancer care we provide patients who come to MD Anderson seeking our innovative approaches, world-renowned expertise and decades of experience is a true honor,” said Marshall Hicks, M.D., president ad interim of MD Anderson. “This ranking recognizes the passion of our 20,000 extraordinary employees and 1,000 volunteers for serving our patients and realizing our mission to end cancer. We are grateful, honored and proud to be the top-ranked cancer center in this national survey.”

Two MD Anderson subspecialties also were ranked high in the survey. In the Ear, Nose and Throat specialty, the Head and Neck Surgery service was ranked No. 15, and in Gynecology, Gynecologic Oncology and Reproductive Medicine ranked No. 17. These two specialties consistently have been ranked for the last two decades. The survey also ranked MD Anderson as “High Performing” in Diabetes & Endocrinology, Orthopedics and Urology.

MD Anderson’s commitment to patients and its mission to end cancer has driven the institution for more than 75 years and continues to fuel its efforts to raise the level of cancer care all over the world. Serving nearly 135,000 patients last year in the Texas Medical Center and throughout the Houston region, MD Anderson also extends its standard of care by collaborating with community hospitals and health systems all over the world. Combined with other initiatives in prevention, research and education, MD Anderson’s outreach enables millions of local, domestic and international patients to have greater access to its expertise, experience and innovation.

“This recognition from U.S. News & World Report is a reminder that patients are at the center of all we do now and all we envision for the future,” said Stephen Hahn, M.D., deputy president and chief operating officer. “Our mission is bold, but it’s through innovative care, research, education and prevention that we will fulfill our promise to end cancer. It’s what we strive for every day.”